{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:39:33Z","timestamp":1775201973239,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences","award":["CI2024E003KC-18, CI2021A04910, CI2021B015"],"award-info":[{"award-number":["CI2024E003KC-18, CI2021A04910, CI2021B015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Golden bile powder (GBP), an artificial bear bile powder, is used for liver protection and contains taurine-conjugated bile acids (BAs) with broad pharmacological activities. However, its pharmacokinetics and effects on endogenous BA homeostasis are unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sprague\u2013Dawley rats received oral administration of GBP (54\u00a0mg\/kg\/day) combined with three deuterated taurine-conjugated BAs at fixed ratios for 7\u00a0days to facilitate separate analysis of changes in exogenous and endogenous BAs following administration. Single deuterated taurine-conjugated BA groups were also included. Blood samples were collected over a 24\u00a0h time window on days 1 and 7. We developed and validated a surrogate analyte-based UPLC-MS\/MS method to quantify six BAs in rat plasma, eliminating endogenous interference. Pharmacokinetic parameters were obtained by non-compartmental analysis, and gender differences and accumulation effects were assessed using appropriate statistical comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The UPLC-MS\/MS method demonstrated good linearity (r\u2009&gt;\u20090.999), accuracy (89.1%\u2013115%), precision (RSD\u2009&lt;\u200915%), and stability (within\u2009\u00b1\u200915%). Pharmacokinetic studies showed taurine-conjugated BAs in GBP had long half-lives (8.43\u201312.7\u00a0h) and gender-specific accumulation, with females displaying higher systemic exposure. For example, the AUC\n                      <jats:sub>0-24\u00a0h<\/jats:sub>\n                      of TCA was approximately 16-fold higher in females than in males. Repeated GBP administration (54\u00a0mg\/kg\/day for 7\u00a0days) reshaped systemic BA composition, increasing both exogenous and endogenous BA concentrations, with the latter displaying more pronounced elevations\u2014approximately fivefold higher than the exogenous BA AUC increase. Sex differences were evident, as female rats exhibited enhanced conversion of conjugated BAs to free forms. The BA shifts observed may be related to known enterohepatic circulation and gut microbiota-mediated BA transformation pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This work establishes an analytical framework for evaluating endogenous and exogenous BA dynamics, contributing to future mechanistic and translational studies involving GBP and its potential applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01371-7","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:26:36Z","timestamp":1775193996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics and homeostatic impact of golden bile powder: evidence from surrogate analyte-based UPLC-MS\/MS in rats"],"prefix":"10.1186","volume":"21","author":[{"given":"Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhishan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiutao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baolin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"5","key":"1371_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-022-04278-2","volume":"79","author":"T Re\u017een","year":"2022","unstructured":"Re\u017een T, Rozman D, Kov\u00e1cs T, Kov\u00e1cs P, Sipos A, Bai P, et al. The role of bile acids in carcinogenesis. Cell Mol Life Sci. 2022;79(5):1\u201339. https:\/\/doi.org\/10.1007\/s00018-022-04278-2.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1371_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2017","unstructured":"Jia W, Xie G, Jia W. Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2017;15(2):111\u201328. https:\/\/doi.org\/10.1038\/nrgastro.2017.119.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"1371_CR3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678\u201393. https:\/\/doi.org\/10.1038\/nrd2619.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1371_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/01480545.2012.658919","volume":"36","author":"D Sokolovic","year":"2013","unstructured":"Sokolovic D, Nikolic J, Kocic G, Jevtovic-Stoimenov T, Veljkovic A, Stojanovic M, et al. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation. Drug Chem Toxicol. 2013;36(2):141\u20138. https:\/\/doi.org\/10.3109\/01480545.2012.658919.","journal-title":"Drug Chem Toxicol"},{"key":"1371_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fmed.2020.00015","volume":"7","author":"V Meadows","year":"2020","unstructured":"Meadows V, Kennedy L, Kundu D, Alpini G, Francis H. Bile acid receptor therapeutics effects on chronic liver diseases. Front Med. 2020;7:15. https:\/\/doi.org\/10.3389\/fmed.2020.00015.","journal-title":"Front Med"},{"issue":"1","key":"1371_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","volume":"82","author":"CD Fuchs","year":"2025","unstructured":"Fuchs CD, Simbrunner B, Baumgartner M, Campbell C, Reiberger T, Trauner M. Bile acid metabolism and signalling in liver disease. J Hepatol. 2025;82(1):134\u201353. https:\/\/doi.org\/10.1016\/j.jhep.2024.09.032.","journal-title":"J Hepatol"},{"issue":"1","key":"1371_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12934-024-02592-x","volume":"23","author":"S Tang","year":"2024","unstructured":"Tang S, Pan Y, Yang Q, Lou D, Zhu L, Tan J, et al. Synthesis of TUDCA from chicken bile: immobilized dual-enzymatic system for producing artificial bear bile substitute. Microb Cell Fact. 2024;23(1):326. https:\/\/doi.org\/10.1186\/s12934-024-02592-x.","journal-title":"Microb Cell Fact"},{"issue":"7395","key":"1371_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/484455c","volume":"484","author":"X Sheng","year":"2012","unstructured":"Sheng X, Zhang H, Weng Q. Traditional Chinese medicine: China\u2019s bear farms prompt public outcry. Nature. 2012;484(7395):455. https:\/\/doi.org\/10.1038\/484455c.","journal-title":"Nature"},{"key":"1371_CR9","doi-asserted-by":"publisher","first-page":"114829","DOI":"10.1016\/j.jep.2021.114829","volume":"284","author":"J Cai","year":"2022","unstructured":"Cai J, Wu J, Fang S, Liu S, Wang T, Li Y, et al. Cultured bear bile powder ameliorates acute liver injury in cholestatic mice via inhibition of hepatic inflammation and apoptosis. J Ethnopharmacol. 2022;284:114829. https:\/\/doi.org\/10.1016\/j.jep.2021.114829.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1371_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11655-019-3010-1","volume":"26","author":"HW Chen","year":"2020","unstructured":"Chen HW, Shen AL, Liu LY, Peng J, Chu JF. Bear bile powder inhibits growth of hepatocellular carcinoma via suppressing STAT3 signaling pathway in mice. Chin J Integr Med. 2020;26(5):370\u20134. https:\/\/doi.org\/10.1007\/s11655-019-3010-1.","journal-title":"Chin J Integr Med"},{"key":"1371_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/bs.irn.2017.02.008","volume":"135","author":"S Appiah","year":"2017","unstructured":"Appiah S, Revitt M, Jones H, Vu M, Simmonds M, Bell C. Antiinflammatory and hepatoprotective medicinal herbs as potential substitutes for bear bile. Int Rev Neurobiol. 2017;135:149\u201380. https:\/\/doi.org\/10.1016\/bs.irn.2017.02.008.","journal-title":"Int Rev Neurobiol"},{"key":"1371_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112998","volume":"262","author":"X Sun","year":"2020","unstructured":"Sun X, Xue H, Zan B, Zhao Y, Li Y, Wang T, et al. Anti-convulsant effects of cultures bear bile powder in febrile seizure via regulation of neurotransmission and inhibition of neuroinflammation. J Ethnopharmacol. 2020;262:112998. https:\/\/doi.org\/10.1016\/j.jep.2020.112998.","journal-title":"J Ethnopharmacol"},{"key":"1371_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1090955","volume":"13","author":"XL Chen","year":"2022","unstructured":"Chen XL, Cai K, Zhang W, Su SL, Zhao LH, Qiu LP, et al. Bear bile powder ameliorates type 2 diabetes via modulation of metabolic profiles, gut microbiota, and metabolites. Front Pharmacol. 2022;13:1090955. https:\/\/doi.org\/10.3389\/fphar.2022.1090955.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1371_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-025-01060-x","volume":"20","author":"Y Luo","year":"2025","unstructured":"Luo Y, Zhang F, Zhu L, Ye J, Pan HY, Lu X, et al. Efficacy and compatibility mechanism of bear bile powder in Shexiang Tongxin dropping pills for acute myocardial infarction treatment. Chin Med. 2025;20(1):14. https:\/\/doi.org\/10.1186\/s13020-025-01060-x.","journal-title":"Chin Med"},{"issue":"2","key":"1371_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00216-022-04413-9","volume":"415","author":"M Yuan","year":"2023","unstructured":"Yuan M, Gong S, Liu Y, Li X, Li M, Zeng D, et al. Rapid discrimination of the authenticity and geographical origin of bear bile powder using stable isotope ratio and elemental analysis. Anal Bioanal Chem. 2023;415(2):345\u201356. https:\/\/doi.org\/10.1007\/s00216-022-04413-9.","journal-title":"Anal Bioanal Chem"},{"key":"1371_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2023.100674","volume":"32","author":"F Huang","year":"2023","unstructured":"Huang F, Mariani N, Pariante CM, Borsini A. From dried bear bile to molecular investigation of differential effects of bile acids in ex vivo and in vitro models of myocardial dysfunction: relevance for neuroinflammation. Brain Behav Immun Health. 2023;32:100674. https:\/\/doi.org\/10.1016\/j.bbih.2023.100674.","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"1371_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-024-00912-2","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zou Z, Wang S, Ren A, Ding Z, Li Y, et al. Golden bile powder prevents drunkenness and alcohol-induced liver injury in mice via the gut microbiota and metabolic modulation. Chin Med. 2024;19(1):1\u201317. https:\/\/doi.org\/10.1186\/s13020-024-00912-2.","journal-title":"Chin Med"},{"issue":"2","key":"1371_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ab.2012.09.035","volume":"432","author":"K Kinoshita","year":"2013","unstructured":"Kinoshita K, Jingu S, Yamaguchi J. A surrogate analyte method to determine D-serine in mouse brain using liquid chromatography-tandem mass spectrometry. Anal Biochem. 2013;432(2):124\u201330. https:\/\/doi.org\/10.1016\/j.ab.2012.09.035.","journal-title":"Anal Biochem"},{"key":"1371_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114028","volume":"198","author":"K Agrawal","year":"2021","unstructured":"Agrawal K, Voggu RR, Pisek D, Becht S, Chudnovskiy R, Dufour GM, et al. A validated surrogate analyte LC-MS\/MS assay for quantification of endogenous cortisol in human whole blood. J Pharm Biomed Anal. 2021;198:114028. https:\/\/doi.org\/10.1016\/j.jpba.2021.114028.","journal-title":"J Pharm Biomed Anal"},{"key":"1371_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchromb.2016.07.041","volume":"1033-1034","author":"TM Binz","year":"2016","unstructured":"Binz TM, Braun U, Baumgartner MR, Kraemer T. Development of an LC-MS\/MS method for the determination of endogenous cortisol in hair using (13)C3-labeled cortisol as surrogate analyte. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1033\u20131034:65\u201372. https:\/\/doi.org\/10.1016\/j.jchromb.2016.07.041.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1371_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2015.09.005","volume":"1003","author":"K Kinoshita","year":"2015","unstructured":"Kinoshita K, Arai K, Kawaura K, Hiyoshi T, Yamaguchi J. Development, validation, and application of a surrogate analyte method for determining N-acetyl-l-aspartyl-l-glutamic acid levels in rat brain, plasma, and cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1003:1\u201311. https:\/\/doi.org\/10.1016\/j.jchromb.2015.09.005.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"7","key":"1371_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4835","volume":"34","author":"B Zan","year":"2020","unstructured":"Zan B, Liu X, Zhao Y, Shi R, Sun X, Wang T, et al. A validated surrogate analyte UPLC\u2013MS\/MS assay for quantitation of TUDCA, TCDCA, UDCA and CDCA in rat plasma: application in a pharmacokinetic study of cultured bear bile powder. Biomed Chromatogr. 2020;34(7):e4835. https:\/\/doi.org\/10.1002\/bmc.4835.","journal-title":"Biomed Chromatogr"},{"issue":"3","key":"1371_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrd1037","volume":"2","author":"G Lappin","year":"2003","unstructured":"Lappin G, Garner RC. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs. Nat Rev Drug Discov. 2003;2(3):233\u201340. https:\/\/doi.org\/10.1038\/nrd1037.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1371_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/bdd.1923","volume":"36","author":"C Scheerans","year":"2015","unstructured":"Scheerans C, Heinig R, Mueck W. Proposal for defining the relevance of drug accumulation derived from single dose study data for modified release dosage forms. Biopharm Drug Dispos. 2015;36(2):93\u2013103. https:\/\/doi.org\/10.1002\/bdd.1923.","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"1371_CR25","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/molecules27061983","volume":"27","author":"Y Shulpekova","year":"2022","unstructured":"Shulpekova Y, Shirokova E, Zharkova M, Tkachenko P, Tikhonov I, Stepanov A, et al. A recent ten-year perspective: bile acid metabolism and signaling. Molecules. 2022;27(6):1983. https:\/\/doi.org\/10.3390\/molecules27061983.","journal-title":"Molecules"},{"key":"1371_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105812","volume":"162","author":"Z Vinarov","year":"2021","unstructured":"Vinarov Z, Abdallah M, Agundez JAG, Allegaert K, Basit AW, Braeckmans M, et al. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: an UNGAP review. Eur J Pharm Sci. 2021;162:105812. https:\/\/doi.org\/10.1016\/j.ejps.2021.105812.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"1371_CR27","doi-asserted-by":"publisher","first-page":"G549","DOI":"10.1152\/ajpgi.00152.2020","volume":"319","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhang J. Bile acid metabolism and circadian rhythms. Am J Physiol Gastrointest Liver Physiol. 2020;319(5):G549\u201363. https:\/\/doi.org\/10.1152\/ajpgi.00152.2020.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"1371_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/dmd.120.000166","volume":"49","author":"C Ma","year":"2021","unstructured":"Ma C, Guo Y, Klaassen CD. Effect of gender and various diets on bile acid profile and related genes in mice. Drug Metab Dispos. 2021;49(1):62\u201371. https:\/\/doi.org\/10.1124\/dmd.120.000166.","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"1371_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/apt.16602","volume":"54","author":"B Simbrunner","year":"2021","unstructured":"Simbrunner B, Trauner M, Reiberger T. Review article: therapeutic aspects of bile acid signalling in the gut-liver axis. Aliment Pharmacol Ther. 2021;54(10):1243\u201362. https:\/\/doi.org\/10.1111\/apt.16602.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1371_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1194\/jlr.R054114","volume":"56","author":"PA Dawson","year":"2015","unstructured":"Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res. 2015;56(6):1085\u201399. https:\/\/doi.org\/10.1194\/jlr.R054114.","journal-title":"J Lipid Res"},{"issue":"4","key":"1371_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","volume":"66","author":"T Li","year":"2014","unstructured":"Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 2014;66(4):948\u201383. https:\/\/doi.org\/10.1124\/pr.113.008201.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1371_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-023-00490-2","volume":"14","author":"JA Santos-Marcos","year":"2023","unstructured":"Santos-Marcos JA, Mora-Ortiz M, Tena-Sempere M, Lopez-Miranda J, Camargo A. Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases. Biol Sex Differ. 2023;14(1):4. https:\/\/doi.org\/10.1186\/s13293-023-00490-2.","journal-title":"Biol Sex Differ"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01371-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:26:37Z","timestamp":1775193997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01371-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1371"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01371-7","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment protocol was approved by the Ethics Committee of the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, and conducted in accordance with relevant ethical guidelines and regulations (ethical number: 2021B169).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}